MUROMONAB-CD3 for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where MUROMONAB-CD3 was used for Bone marrow conditioning regimen.
Most Reported Side Effects for MUROMONAB-CD3
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Post transplant lymphoproliferative disorder | 22 | 19.3% | 3 | 14 |
| Infection | 16 | 14.0% | 6 | 3 |
| Cytomegalovirus infection | 13 | 11.4% | 5 | 4 |
| Cytomegalovirus oesophagitis | 10 | 8.8% | 1 | 0 |
| Drug resistance | 10 | 8.8% | 1 | 0 |
| Duodenitis | 10 | 8.8% | 1 | 1 |
| Gastritis | 10 | 8.8% | 1 | 1 |
| Weight decreased | 10 | 8.8% | 1 | 0 |
| Chest pain | 9 | 7.9% | 1 | 0 |
| Cytomegalovirus chorioretinitis | 9 | 7.9% | 0 | 0 |
| Cytomegalovirus infection reactivation | 9 | 7.9% | 1 | 0 |
| Encephalitis | 9 | 7.9% | 1 | 0 |
| Gastric fistula | 9 | 7.9% | 1 | 0 |
| Gastric ulcer | 9 | 7.9% | 1 | 0 |
| Gastrointestinal ulcer | 9 | 7.9% | 1 | 0 |
Other Indications for MUROMONAB-CD3
Immunosuppressant drug therapy (38)
Prophylaxis against transplant rejection (20)
Prophylaxis against graft versus host disease (13)
Immunosuppression (12)
Transplant rejection (12)
Product used for unknown indication (11)
Allogenic stem cell transplantation (5)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)